Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[Buddhahead]

Keystone Symposia-NF-kappaB and MAP Kinase Signaling in Inflammation, March 13-17,2016 (Molecular and Cellular Biology)

Topics:

NF-kappaB Signaling in Cancer

Regulation of the Ubiquitin System by Deubiquitylases and Phosphorylation

NF-kappaB Signaling in Immunity

Role of Ubiquitylation in Control of Autophagy

Ubiquitination-Dependent Modulation of NF-kappaB Signaling I (Joint)

Transcriptional Regulation in Inflammation

Large Machines

NLR Signaling to NF-kappaB and IRF

Ubiquitylation and Human Disease

MAP Kinase Signaling in Inflammation

Structural Analysis of E3 Ligases and DUBs

Therapeutic Targeting of Inflammation

Small Molecules and Therapeutics

Ubiquitin-Dependent Modulation of NF-kappaB Signaling II (Joint)

Meeting Wrap-Up: Outcomes and Future Directions




Draft agenda at:
http://www.keystonesymposia.org/16X4